The experimental study of genetic engineering human neural stem cells mediated by lentivirus to express multigene

Chinese Journal of Traumatology - English Edition

Volumn 9, Issue 1, 2006, Pages 43-49

  Cai, Pei Qiang ^a   Tang, Xun ^b   Lin, Yue Qiu ^b   Martin, Oudega ^c   Sun, Guang Yun ^a   Xu, Lin ^d   Yang, Yun Kang ^b   Zhou, Tian Hua ^b  

^a First People's Hospital of Yibin   (China)

^b KUNMING GENERAL HOSPITAL   (China)

^c UNIVERSITY OF MIAMI   (United States)

^d KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

Genetic engineering; Green fluorescence proteins; Human neural stem cell; Lentivirus; Neurotrophin 3

Indexed keywords

GREEN FLUORESCENT PROTEIN; NEUROTROPHIN 3;

ARTICLE; BRAIN CORTEX; CELL CULTURE; CELL ISOLATION; CULTURE MEDIUM; DNA MODIFICATION; EXPERIMENTAL STUDY; FETUS; FLUORESCENCE MICROSCOPY; GENE CONSTRUCT; GENE EXPRESSION; GENETIC ENGINEERING; HUMAN; HUMAN CELL; HUMAN TISSUE; LENTIVIRINAE; NERVE FIBER GROWTH; NEURAL STEM CELL; SLOT BLOT HYBRIDIZATION; SPINAL CORD INJURY; SPINAL GANGLION; TRANSGENE;

EID: 32044455773     PISSN: 10081275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Widenfalk J, Lundstromer K, Jubran M, et al. Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J Neurosci 2001;21:3457-3475.
2. Fournier AE, Strittmatter SM. Repulsive factors and axon regeneration in the CNS. Curr Opin Neurol 2001;11:89-94.
3. Weidner N, Grill RJ, Tuszynski MH. Elimination of basal lamina and the collagen "scar" after spinal cord injury fails to augment corticospinal tract regeneration. Exp Neurol 1999;160:40-50.
4. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of adult mammalian central nervous system. Science 1992;255:1707-1710.
5. Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther 2000;7:20-23.
6. Vigna E, Naldini L. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. Gene Med 2000;2:308-316.
7. Costantini LC, Bakowska J, Breake XO, et al. Gene therapy in the CNS. Gene Ther 2000;7:93-109.
8. Burns JC, Friedmann T, Driever W, et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and effcient gene transfer into mammalian and nonmammalian cells. PNAS USA 1993; 90: 8033-8037.
9. Zhu Y, Feuer G, Day S L. et al. Multigene lentivirus vectors based on differential splicing and translational control. Mol Ther 2001;3:375-382.
10. Cui Y, Iwakuma T, Chang LJ. Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function. J Virol 1999;73:6171-6176.
11. Iwakuma T, Cui Y, Chang L. Self-inactivating lentiviral vectors with U3 and U5 modi. cations. J Virol 1999; 261:120-132.
12. Kafri T, Blomer U, Peterson DA, et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 1997;17:314-317.
13. Miyoshi H, Takahashi M, Gage FH, et al. Stable and effcient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA 1997; 94: 10, 319-323.
14. Blomer U, Naldini L, Kafri T, et al. Highly effcient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997;71:6641-6649.
15. Naldini L, Blomer U, Gage FH, et al. Effcient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996;93:382-388.
16. Ogawa Y, Sawamoto K, Miyata T, et al. Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. Neurosci Res 2002;69:925-933.
17. Liu Y, Himes BT, Solowska J, et al. Intraspinal delivery of neurotrophin-3 using neural stem cells genetically modified by recombinant retrovirus. Exp Neurol 1999; 158: 9-26.
18. Lu P, Jones LL, Snyder EY, et al. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003; 181:115-129.
19. Tuszynski MH., Grill R, Jones LL, et al. NT-3 gene delivery elicits growth of chronically injured corticospinal axons and modestly improves functional deficits after chronic scar resection. Expl Neurol 2003; 181:47-56.
20. Lu P, Blesch A, Tuszynski MH. Neurotrophism without neurotropism: BDNF promotes survival but not growth of lesioned corticospinal neurons. J Comp Neurol 2001; 436: 456-470.
21. Chang MY, Son H, Lee YS, et al. Neurons and astrocytes secrete factors that cause stem cells to differentiate into neurons and astrocytes, respectively. Mol Cell Neurosci 2003;23:414-426.
22. Blesch A, Lu P, Tuszynski MH. Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair. Brain Res Bull 2002;57:833-838.